News Jan 27, 2021 Cellvie raises 5 million US dollars The life sciences firm Cellvie has successfully closed a seed funding round. With gross proceeds of 5 million US dollars, the aim now is to furth...
News Jan 27, 2021 Institute develops double antibody against COVID-19 Researchers at the Institute for Research in Biomedicine have managed to combine two antibodies against COVID-19 into a single entity. This doubl...
News Jan 27, 2021 Basel researchers developing universal cancer therapy Researchers from Basel are working on the development of a therapy in which pre-prepared immune cells can be used to treat any form of cancer imm...
News Jan 26, 2021 Opterion Health AG moving to Muttenz Opterion is moving from the canton of Obwalden to Muttenz in the canton of Basel-Landschaft in order to benefit from the local life sciences ecos...
News Jan 20, 2021 Swiss PharmaCan successfully tests anti-COVID drug Swiss PharmaCan and Australia-based MGC Pharma have successfully concluded phase II clinical testing for their COVID-19 therapeutic candidate, Ar...
News Jan 19, 2021 Ticino Ebola drug receives US authorization The United States Food and Drug Administration (FDA) has authorized an Ebola drug developed by two laboratories based in the Greater Zurich Area....
Expertise Dec 22, 2020 What is the procedure for exporting waste? If you want to export waste from Switzerland, certain rules need to be observed. Which permits are required when and when are you exempt? Which d...
News Nov 27, 2020 Dottikon ES to build new production plant Dottikon ES is building a new chemical production plant for pharmaceutical active ingredients. To achieve this, an investment in the amount of 27...
News Nov 10, 2020 Memo Therapeutics raises 14 million Swiss francs The biotechnology company Memo Therapeutics has raised a total of 14 million Swiss francs as part of a Series B financing round. This should now ...
Member of the Month Nov 10, 2020 "Our goal is to further expand the international presence" Max Zeller Söhne AG's herbal medicines are available in more than 25 countries. The company has successfully build up its international business ...
News Oct 27, 2020 Enespa starts recycling plastic refuse Enespa has developed a machine that produces liquid paraffin from mixed plastics refuse. The first module has now been delivered. Over the next 1...
News Oct 16, 2020 Polyphor receives up to 18 million dollars for development of antibiotics The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X to combat antimicrobial resistance. Po...
News Oct 07, 2020 Lonza to start manufacturing Moderna’s Covid-19 vaccine this December Lonza's new building dedicated to the manufacturing of Moderna's Covid-19 vaccine will be operational starting December 2020. 300 million doses w...
News Sep 17, 2020 Investors see great potential in Polyneuron The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million Swiss francs. I...
News Sep 16, 2020 Lonza set to manufacture coronavirus drug for Humanigen The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonz...
News Sep 07, 2020 Roche testing for coronavirus and flu simultaneously The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that simultaneously tests...
News Sep 01, 2020 Polyphor awarded exclusive licensing agreement for China The Basel Area-based company Polyphor has signed an exclusive licensing agreement with Fosun Pharma in China. Fosun Pharma will lead clinical dev...
Expertise Aug 26, 2020 The potential positive economic and climate impacts of a more Circular Economy How can circular economy provide a model that enables our economies to grow while maintaining our planetary boundaries? Let us present a brief su...